Literature DB >> 8410217

Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2.

M B Bracken1, T R Holford.   

Abstract

Previous analyses of the National Acute Spinal Cord Injury Study (NASCIS) have not distinguished recovery of segmental function at the injury level from recovery of the long spinal tracts. Recovery at the injury level could be of considerable clinical significance, but long-tract recovery is the ultimate therapeutic goal. This analysis demonstrates that the greatest proportion of all neurological recovery and of recovery due to treatment with very high doses of methylprednisolone within 8 hours of injury occurs below the lesion. Methylprednisolone treatment administered early following injury has been found to improve recovery below the lesion in patients initially diagnosed as having complete or incomplete injuries; it also leads to greater (but still relatively small) improvement in the injury level. The analysis indicates that delayed treatment with methylprednisolone is associated with decreased neurological recovery. Naloxone administration also improved neurological function below the lesion in patients with incomplete injuries; these results support further experimental work with this drug. This observation of differential neurological response within a narrow treatment window has important implications for both experimental studies and clinical management. Early clinical management with high-dose methylprednisolone is supported by this analysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410217     DOI: 10.3171/jns.1993.79.4.0500

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  32 in total

Review 1.  Emergency Neurologic Life Support: Spinal Cord Compression.

Authors:  Kristine H O'Phalen; E Bradshaw Bunney; John W Kuluz
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

Review 2.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 3.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

Review 4.  Neuroprotection and acute spinal cord injury: a reappraisal.

Authors:  Edward D Hall; Joe E Springer
Journal:  NeuroRx       Date:  2004-01

Review 5.  Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies.

Authors:  Alexander G Yakovlev; Alan I Faden
Journal:  NeuroRx       Date:  2004-01

6.  Neurotherapeutics. Editorial.

Authors:  Edward D Hall; Stephen M Onifer
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 7.  Trends in neuroanaesthesia.

Authors:  J E Cottrell
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

8.  Traumatic Optic Neuropathy-The Many Presentations and Treatment Options.

Authors:  Celia Chen
Journal:  Neuroophthalmology       Date:  2014-05-14

Review 9.  Optic nerve monitoring.

Authors:  Paul Schumann; Horst Kokemüller; Frank Tavassol; Daniel Lindhorst; Juliana Lemound; Harald Essig; Martin Rücker; Nils-Claudius Gellrich
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-05-01

Review 10.  Post-traumatic visual loss.

Authors:  Edward J Atkins; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.